Acquired inhibitors (Q41107876)

26 September 2017

1 reference

title

Acquired inhibitors (English)

1 reference

26 September 2017

A J Cohen

1

1 reference

26 September 2017

C M Kessler

series ordinal

2

1 reference

26 September 2017

publication date

1 June 1996

1 reference

Best Practice and Research: Clinical Haematology

26 September 2017

published in

1 reference

26 September 2017

volume

9

1 reference

26 September 2017

issue

2

1 reference

26 September 2017

page(s)

331-354

1 reference

Demonstration of abnormal factor VIII multimers in acquired von Willebrand's disease associated with a circulating inhibitor

26 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

The mode of action of antibodies which destroy factor VIII. II. Antibodies which give complex concentration graphs

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Platelet dysfunction associated with Wilms tumor and hyaluronic acid

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

1 reference

7 January 2021

Effectiveness of high-dose intravenous immunoglobulin in a case of acquired von Willebrand syndrome with chronic melena not responsive to desmopressin and factor VIII concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Acquired factor VIII inhibitor associated with chronic interferon-alpha therapy in a patient with haemophilia A.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Circulating Anticoagulants Against Factors IX and XI in Systemic Lupus Erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Acute myocardial infarction during treatment with an activated prothrombin complex concentrate in a patient with factor VIII deficiency and a factor VIII inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Studies on a circulating anticoagulant inhibiting factor XI in a patient with congenital deficiency and carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Acquired von Willebrand disease in Wilms' tumor patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Hypothyroidism as a cause of acquired von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Intracerebral haemorrhage due to acquired factor XIII inhibitor???successful response to factor XIII concentrate

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

The effect of 1-deamino 8 D-arginine vasopressin (DDAVP) in a nonhaemophilic patient with an acquired type II factor VIII inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Acquired type II von Willebrand's disease associated with adrenal cortical carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Laboratory evidence of DIC under FEIBA treatment of a hemophilic patient with intracranial bleeding and high titre factor VIII inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Pathogenesis of antibody-induced acquired von Willebrand Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

A circulating anticoagulant in gamma-1A-multiple myeloma: its modification by penicillin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Acquired factor XI inhibitor in chronic lymphocytic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Factor VIIa in the treatment of haemophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Syndrome of an acquired inhibitor of factor VIII responsive to cyclophosphamide and prednisone

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Development of Antibodies to Bovine and Human Factor V in Two Children After Exposure to Topical Bovine Thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Fatal Hemorrhage in a Patient with an Acquired Inhibitor of Human Thrombin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Acquired factor-IX inhibitor in a nonhaemophilic patient with autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Variable inactivation of human factor VIII from different sources by human factor VIII inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

An IgM circulating anticoagulant with factor VIII inhibitory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Acquired factor VIII inhibitor preceding chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Spontaneously acquired factor IX inhibitor in a nonhemophiliac child

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Acquired von Willebrand disease in patients with polycythemia rubra vera

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Bleeding tendency caused by IgG inhibitor to factor XIII, treated successfully by cyclophosphamide

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Acquired factor IX deficiency. A report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Cyclosporin treatment of a woman with acquired haemophilia due to factor VIII:C inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Acquired von Willebrand's disease: demonstration of a circulating inhibitor to the factor VIII complex in four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Unusual circulating anticoagulant in a patient with systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Acquired factor XI inhibitors in congenitally deficient patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Successful treatment of a patient with postpartum factor VIII inhibitor with recombinant human interferon alpha 2a

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Spontaneous factor VIII inhibitor occurring in association with chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

The efficacy of intensive plasma exchange in acquired von Willebrand's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

The role of intensive plasma exchange in the prevention and management of haemorrhage in patients with inhibitors to factor VIII

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980067-9

7 January 2021

10.1016/S0950-3536(96)80067-9

Identifiers

DOI

1 reference

26 September 2017

1 reference